Clinical Trials Sponsored by Teva Pharmaceuticals Europe

Total 708 results

Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Cilostazol 50 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Non-Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Finasteride 5 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Desmopressin Acetate 0.2 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Finasteride 5 mg Tablets, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ropinirole 0.25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ribavirin 200 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ursodiol 500 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ursodiol Tablets 500 mg Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 40 mg Tablets Food Challenge Study

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Bioequivalence

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Valacyclovir 1000 mg Tablet Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Healthy

United States

3

Subscribe